Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021

Upgrades

Morgan Stanley upgraded the previous rating for EQT Corp EQT from Equal-Weight to Overweight. For the third quarter, EQT had an EPS of $0.12, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $23.24 and a 52-week-low of $12.27. EQT closed at $21.10 at the end of the last trading period.
According to Goldman Sachs, the prior rating for Intuit Inc INTU was changed from Neutral to Buy. In the first quarter, Intuit showed an EPS of $1.53, compared to $0.94 from the year-ago quarter. The current stock performance of Intuit shows a 52-week-high of $646.48 and a 52-week-low of $337.72. Moreover, at the end of the last trading period, the closing price was at $628.94.
For Tapestry Inc TPR, Argus Research upgraded the previous rating of Hold to Buy. Tapestry earned $0.82 in the first quarter, compared to $0.58 in the year-ago quarter. The stock has a 52-week-high of $49.66 and a 52-week-low of $27.62. At the end of the last trading period, Tapestry closed at $45.84.
Wolfe Research upgraded the previous rating for Delta Air Lines Inc DAL from Peer Perform to Outperform. Delta Air Lines earned $0.30 in the third quarter, compared to $3.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.28 and a 52-week-low of $36.97. Delta Air Lines closed at $40.12 at the end of the last trading period.
For Southwest Airlines Co LUV, Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the third quarter, Southwest Airlines had an EPS of $0.23, compared to year-ago quarter EPS of $1.99. The current stock performance of Southwest Airlines shows a 52-week-high of $64.75 and a 52-week-low of $43.72. Moreover, at the end of the last trading period, the closing price was at $46.37.
According to RBC Capital, the prior rating for Datadog Inc DDOG was changed from Sector Perform to Outperform. In the third quarter, Datadog showed an EPS of $0.13, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $199.68 and a 52-week-low of $69.73. At the end of the last trading period, Datadog closed at $190.60.
According to MKM Partners, the prior rating for Walmart Inc WMT was changed from Neutral to Buy. Walmart earned $1.45 in the third quarter, compared to $1.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $153.66 and a 52-week-low of $126.28. Walmart closed at $143.16 at the end of the last trading period.
According to Wells Fargo, the prior rating for Matador Resources Co MTDR was changed from Equal-Weight to Overweight. For the third quarter, Matador Resources had an EPS of $1.25, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $47.23 and a 52-week-low of $8.91. Matador Resources closed at $42.51 at the end of the last trading period.
According to Wells Fargo, the prior rating for Callon Petroleum Co CPE was changed from Underweight to Equal-Weight. Callon Petroleum earned $2.93 in the third quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $65.45 and a 52-week-low of $7.50. At the end of the last trading period, Callon Petroleum closed at $57.78.
For Ingersoll Rand Inc IR, Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, Ingersoll Rand had an EPS of $0.57, compared to year-ago quarter EPS of $0.40. The current stock performance of Ingersoll Rand shows a 52-week-high of $61.26 and a 52-week-low of $40.64. Moreover, at the end of the last trading period, the closing price was at $60.90.
According to Goldman Sachs, the prior rating for Horizon Therapeutics PLC HZNP was changed from Neutral to Buy. Horizon Therapeutics earned $1.75 in the third quarter, compared to $1.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.53 and a 52-week-low of $66.41. Horizon Therapeutics closed at $107.19 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Athersys Inc ATHX, B of A Securities downgraded the previous rating of Buy to Neutral. In the third quarter, Athersys showed an EPS of $0.07, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $3.03 and a 52-week-low of $1.10. At the end of the last trading period, Athersys closed at $1.13.
For Avrobio Inc AVRO, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Avrobio earned $0.75 in the third quarter, compared to $1.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.07 and a 52-week-low of $4.63. Avrobio closed at $4.71 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Rhythm Pharmaceuticals Inc RYTM was changed from Overweight to Equal-Weight. For the third quarter, Rhythm Pharmaceuticals had an EPS of $0.70, compared to year-ago quarter EPS of $0.77. The current stock performance of Rhythm Pharmaceuticals shows a 52-week-high of $43.26 and a 52-week-low of $10.70. Moreover, at the end of the last trading period, the closing price was at $11.44.
For Karyopharm Therapeutics Inc KPTI, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Karyopharm Therapeutics earned $0.69 in the third quarter, compared to $0.73 in the year-ago quarter. The current stock performance of Karyopharm Therapeutics shows a 52-week-high of $18.00 and a 52-week-low of $4.42. Moreover, at the end of the last trading period, the closing price was at $8.24.
According to Benchmark, the prior rating for Vipshop Holdings Ltd VIPS was changed from Buy to Hold. Vipshop Holdings earned $0.23 in the third quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $46.00 and a 52-week-low of $9.81. At the end of the last trading period, Vipshop Holdings closed at $10.03.
Morgan Stanley downgraded the previous rating for Range Resources Corp RRC from Equal-Weight to Underweight. Range Resources earned $0.52 in the third quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Range Resources shows a 52-week-high of $26.48 and a 52-week-low of $6.19. Moreover, at the end of the last trading period, the closing price was at $22.00.
Morgan Stanley downgraded the previous rating for Schrodinger Inc SDGR from Overweight to Equal-Weight. Schrodinger earned $0.49 in the third quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Schrodinger shows a 52-week-high of $117.00 and a 52-week-low of $41.26. Moreover, at the end of the last trading period, the closing price was at $41.66.
For Zendesk Inc ZEN, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. In the third quarter, Zendesk showed an EPS of $0.17, compared to $0.17 from the year-ago quarter. The stock has a 52-week-high of $166.60 and a 52-week-low of $92.00. At the end of the last trading period, Zendesk closed at $97.76.
According to B. Riley Securities, the prior rating for American Software Inc AMSWA was changed from Buy to Neutral. For the second quarter, American Software had an EPS of $0.12, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $33.27 and a 52-week-low of $15.74. At the end of the last trading period, American Software closed at $30.51.
For Snowflake Inc SNOW, Rosenblatt downgraded the previous rating of Buy to Neutral. At the moment, the stock has a 52-week-high of $429.00 and a 52-week-low of $184.71. Snowflake closed at $397.43 at the end of the last trading period.
According to Compass Point, the prior rating for Regency Centers Corp REG was changed from Buy to Neutral. Regency Centers earned $1.12 in the third quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $78.06 and a 52-week-low of $43.49. At the end of the last trading period, Regency Centers closed at $74.76.
For Sirius XM Holdings Inc SIRI, Barclays downgraded the previous rating of Equal-Weight to Underweight. For the third quarter, Sirius XM Holdings had an EPS of $0.10, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $8.14 and a 52-week-low of $5.75. Sirius XM Holdings closed at $6.32 at the end of the last trading period.
For Dicerna Pharmaceuticals Inc DRNA, RBC Capital downgraded the previous rating of Outperform to Sector Perform. For the third quarter, Dicerna Pharmaceuticals had an EPS of $0.22, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $40.14 and a 52-week-low of $19.06. Dicerna Pharmaceuticals closed at $38.03 at the end of the last trading period.
For Vertex Pharmaceuticals Inc VRTX, Piper Sandler downgraded the previous rating of Overweight to Neutral. For the third quarter, Vertex Pharmaceuticals had an EPS of $3.56, compared to year-ago quarter EPS of $2.64. The current stock performance of Vertex Pharmaceuticals shows a 52-week-high of $242.99 and a 52-week-low of $176.36. Moreover, at the end of the last trading period, the closing price was at $185.41.

See all analyst ratings downgrades.

Initiations

With an Overweight rating, JP Morgan initiated coverage on Missfresh Ltd MF. The price target seems to have been set at ('$5.70', False) for Missfresh. The current stock performance of Missfresh shows a 52-week-high of $11.00 and a 52-week-low of $3.52. Moreover, at the end of the last trading period, the closing price was at $4.44.
With a Buy rating, EF Hutton initiated coverage on HCW Biologics Inc HCWB. The price target seems to have been set at ('$10.00', False) for HCW Biologics. In the third quarter, HCW Biologics showed an EPS of $0.14, compared to $0.63 from the year-ago quarter. The current stock performance of HCW Biologics shows a 52-week-high of $7.78 and a 52-week-low of $2.36. Moreover, at the end of the last trading period, the closing price was at $2.86.
Benchmark initiated coverage on Weatherford International PLC WFRD with a Buy rating. The price target for Weatherford International is set to ('$46.00', False). Weatherford International earned $0.63 in the third quarter, compared to $1.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.95 and a 52-week-low of $12.41. Weatherford International closed at $30.07 at the end of the last trading period.
Benchmark initiated coverage on Saia Inc SAIA with a Buy rating. The price target for Saia is set to ('$390.00', False). For the third quarter, Saia had an EPS of $2.86, compared to year-ago quarter EPS of $1.56. The current stock performance of Saia shows a 52-week-high of $365.50 and a 52-week-low of $165.14. Moreover, at the end of the last trading period, the closing price was at $354.49.
With a Hold rating, Benchmark initiated coverage on Schlumberger Ltd SLB. The price target seems to have been set at ('No Price Target', True) for Schlumberger. Schlumberger earned $0.36 in the third quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Schlumberger shows a 52-week-high of $36.87 and a 52-week-low of $19.55. Moreover, at the end of the last trading period, the closing price was at $31.86.
JMP Securities initiated coverage on Prothena Corp PLC PRTA with a Market Outperform rating. The price target for Prothena Corp is set to ('$77.00', False). Prothena Corp earned $2.13 in the third quarter, compared to $0.77 in the year-ago quarter. The stock has a 52-week-high of $79.75 and a 52-week-low of $10.72. At the end of the last trading period, Prothena Corp closed at $54.59.
With a Buy rating, Berenberg initiated coverage on Instructure Holdings Inc INST. The price target seems to have been set at ('$30.00', False) for Instructure Holdings. For the third quarter, Instructure Holdings had an EPS of $0.24, compared to year-ago quarter EPS of $0.13.
Piper Sandler initiated coverage on Replimune Group Inc REPL with an Overweight rating. The price target for Replimune Group is set to ('$52.00', False). Replimune Group earned $0.56 in the second quarter, compared to $0.46 in the year-ago quarter. The current stock performance of Replimune Group shows a 52-week-high of $54.85 and a 52-week-low of $27.66. Moreover, at the end of the last trading period, the closing price was at $33.45.
Benchmark initiated coverage on Halliburton Co HAL with a Buy rating. The price target for Halliburton is set to ('$31.00', False). In the third quarter, Halliburton showed an EPS of $0.28, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.75 and a 52-week-low of $15.04. Halliburton closed at $22.76 at the end of the last trading period.
With a Buy rating, Goldman Sachs initiated coverage on Sema4 Holdings Corp SMFR. The price target seems to have been set at ('$12.00', False) for Sema4 Holdings.
With an Outperform rating, BMO Capital initiated coverage on Candel Therapeutics Inc CADL. The price target seems to have been set at ('$18.00', False) for Candel Therapeutics. In the third quarter, Candel Therapeutics showed an EPS of $0.26, compared to $0.22 from the year-ago quarter.
With an Outperform rating, BMO Capital initiated coverage on Mirati Therapeutics Inc MRTX. The price target seems to have been set at ('$187.00', False) for Mirati Therapeutics. In the third quarter, Mirati Therapeutics showed an EPS of $1.55, compared to $1.96 from the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $249.42 and a 52-week-low of $131.47. Moreover, at the end of the last trading period, the closing price was at $137.45.
BMO Capital initiated coverage on Pfizer Inc PFE with an Outperform rating. The price target for Pfizer is set to ('$60.00', False). For the third quarter, Pfizer had an EPS of $1.34, compared to year-ago quarter EPS of $0.72. The stock has a 52-week-high of $51.86 and a 52-week-low of $33.36. At the end of the last trading period, Pfizer closed at $51.41.
With an Outperform rating, BMO Capital initiated coverage on Bristol-Myers Squibb Co BMY. The price target seems to have been set at ('$72.00', False) for Bristol-Myers Squibb. For the third quarter, Bristol-Myers Squibb had an EPS of $2.00, compared to year-ago quarter EPS of $1.63. At the moment, the stock has a 52-week-high of $69.75 and a 52-week-low of $56.11. Bristol-Myers Squibb closed at $59.04 at the end of the last trading period.
With an Outperform rating, BMO Capital initiated coverage on Eli Lilly and Co LLY. The price target seems to have been set at ('$311.00', False) for Eli Lilly. Eli Lilly earned $1.94 in the third quarter, compared to $1.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $275.87 and a 52-week-low of $138.92. Eli Lilly closed at $261.33 at the end of the last trading period.
With a Market Perform rating, BMO Capital initiated coverage on Incyte Corp INCY. The price target seems to have been set at ('$75.00', False) for Incyte. In the third quarter, Incyte showed an EPS of $1.18, compared to $0.23 from the year-ago quarter. The current stock performance of Incyte shows a 52-week-high of $101.47 and a 52-week-low of $61.91. Moreover, at the end of the last trading period, the closing price was at $65.13.
With an Outperform rating, BMO Capital initiated coverage on Biogen Inc BIIB. The price target seems to have been set at ('$315.00', False) for Biogen. For the third quarter, Biogen had an EPS of $4.77, compared to year-ago quarter EPS of $8.84. At the moment, the stock has a 52-week-high of $468.55 and a 52-week-low of $238.40. Biogen closed at $256.79 at the end of the last trading period.
BMO Capital initiated coverage on Amgen Inc AMGN with a Market Perform rating. The price target for Amgen is set to ('$228.00', False). Amgen earned $4.67 in the third quarter, compared to $4.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $276.69 and a 52-week-low of $200.47. Amgen closed at $204.02 at the end of the last trading period.
BMO Capital initiated coverage on Neurocrine Biosciences Inc NBIX with an Underperform rating. The price target for Neurocrine Biosciences is set to ('$76.00', False). Neurocrine Biosciences earned $0.64 in the third quarter, compared to $0.97 in the year-ago quarter. The current stock performance of Neurocrine Biosciences shows a 52-week-high of $120.27 and a 52-week-low of $84.77. Moreover, at the end of the last trading period, the closing price was at $87.51.
With a Market Perform rating, BMO Capital initiated coverage on Vertex Pharmaceuticals Inc VRTX. The price target seems to have been set at ('$202.00', False) for Vertex Pharmaceuticals. Vertex Pharmaceuticals earned $3.56 in the third quarter, compared to $2.64 in the year-ago quarter. The current stock performance of Vertex Pharmaceuticals shows a 52-week-high of $242.99 and a 52-week-low of $176.36. Moreover, at the end of the last trading period, the closing price was at $185.41.
With a Market Perform rating, BMO Capital initiated coverage on Merck & Co Inc MRK. The price target seems to have been set at ('$91.00', False) for Merck & Co. In the third quarter, Merck & Co showed an EPS of $1.75, compared to $1.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $91.40 and a 52-week-low of $15.32. Merck & Co closed at $83.05 at the end of the last trading period.
With a Buy rating, Jefferies initiated coverage on Axis Capital Holdings Ltd AXS. The price target seems to have been set at ('$65.00', False) for Axis Capital Holdings. In the third quarter, Axis Capital Holdings showed an EPS of $0.01, compared to $0.77 from the year-ago quarter. The stock has a 52-week-high of $58.61 and a 52-week-low of $44.26. At the end of the last trading period, Axis Capital Holdings closed at $52.12.
With an Underperform rating, Jefferies initiated coverage on Progressive Corp PGR. The price target seems to have been set at ('$81.00', False) for Progressive. For the third quarter, Progressive had an EPS of $0.14, compared to year-ago quarter EPS of $1.88. The stock has a 52-week-high of $107.58 and a 52-week-low of $84.89. At the end of the last trading period, Progressive closed at $90.72.
With a Hold rating, Jefferies initiated coverage on American International Group Inc AIG. The price target seems to have been set at ('$64.00', False) for American Intl Gr. In the third quarter, American Intl Gr showed an EPS of $0.97, compared to $0.81 from the year-ago quarter. The stock has a 52-week-high of $62.54 and a 52-week-low of $36.77. At the end of the last trading period, American Intl Gr closed at $56.12.
Jefferies initiated coverage on Allstate Corp ALL with a Hold rating. The price target for Allstate is set to ('$121.00', False). Allstate earned $0.73 in the third quarter, compared to $2.94 in the year-ago quarter. The current stock performance of Allstate shows a 52-week-high of $140.00 and a 52-week-low of $98.15. Moreover, at the end of the last trading period, the closing price was at $113.06.
Jefferies initiated coverage on Lemonade Inc LMND with an Underperform rating. The price target for Lemonade is set to ('$49.00', False). In the third quarter, Lemonade showed an EPS of $1.08, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $188.30 and a 52-week-low of $53.00. Lemonade closed at $54.07 at the end of the last trading period.
With a Hold rating, Jefferies initiated coverage on The Travelers Companies Inc TRV. The price target seems to have been set at ('$165.00', False) for Travelers Companies. In the third quarter, Travelers Companies showed an EPS of $2.60, compared to $3.12 from the year-ago quarter. The stock has a 52-week-high of $163.29 and a 52-week-low of $129.57. At the end of the last trading period, Travelers Companies closed at $156.03.
With a Buy rating, Jefferies initiated coverage on Chubb Ltd CB. The price target seems to have been set at ('$235.00', False) for Chubb. Chubb earned $2.64 in the third quarter, compared to $2.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $197.92 and a 52-week-low of $144.00. Chubb closed at $191.93 at the end of the last trading period.
Jefferies initiated coverage on Root Inc ROOT with a Hold rating. The price target for Root is set to ('$5.50', False). Root earned $0.53 in the third quarter, compared to $2.20 in the year-ago quarter. The current stock performance of Root shows a 52-week-high of $25.63 and a 52-week-low of $4.31. Moreover, at the end of the last trading period, the closing price was at $4.43.
Jefferies initiated coverage on Hippo Holdings Inc HIPO with a Buy rating. The price target for Hippo Holdings is set to ('$8.00', False).
Jefferies initiated coverage on Aon PLC AON with a Hold rating. The price target for Aon is set to ('$313.00', False). In the third quarter, Aon showed an EPS of $1.74, compared to $1.53 from the year-ago quarter. The current stock performance of Aon shows a 52-week-high of $326.25 and a 52-week-low of $197.86. Moreover, at the end of the last trading period, the closing price was at $294.83.
Jefferies initiated coverage on Willis Towers Watson PLC WLTW with a Hold rating. The price target for Willis Towers Watson is set to ('$258.00', False). Willis Towers Watson earned $1.73 in the third quarter, compared to $1.33 in the year-ago quarter. The stock has a 52-week-high of $271.87 and a 52-week-low of $197.63. At the end of the last trading period, Willis Towers Watson closed at $228.44.
Jefferies initiated coverage on Arthur J. Gallagher & Co AJG with a Buy rating. The price target for Arthur J. Gallagher is set to ('$205.00', False). In the third quarter, Arthur J. Gallagher showed an EPS of $1.33, compared to $1.08 from the year-ago quarter. The stock has a 52-week-high of $168.50 and a 52-week-low of $112.92. At the end of the last trading period, Arthur J. Gallagher closed at $162.81.
Jefferies initiated coverage on Brown & Brown Inc BRO with a Buy rating. The price target for Brown & Brown is set to ('$76.00', False). Brown & Brown earned $0.58 in the third quarter, compared to $0.52 in the year-ago quarter. At the moment, the stock has a 52-week-high of $67.24 and a 52-week-low of $42.72. Brown & Brown closed at $64.14 at the end of the last trading period.
Raymond James initiated coverage on Jacobs Engineering Group Inc J with an Outperform rating. The price target for Jacobs Engineering Group is set to ('$170.00', False). In the third quarter, Jacobs Engineering Group showed an EPS of $1.64, compared to $1.26 from the year-ago quarter. The current stock performance of Jacobs Engineering Group shows a 52-week-high of $147.91 and a 52-week-low of $100.05. Moreover, at the end of the last trading period, the closing price was at $147.22.
Stephens & Co. initiated coverage on NCR Corp NCR with an Overweight rating. The price target for NCR is set to ('$55.00', False). For the third quarter, NCR had an EPS of $0.69, compared to year-ago quarter EPS of $0.54. The current stock performance of NCR shows a 52-week-high of $50.00 and a 52-week-low of $24.70. Moreover, at the end of the last trading period, the closing price was at $40.42.
With an Overweight rating, Stephens & Co. initiated coverage on Q2 Holdings Inc QTWO. The price target seems to have been set at ('$100.00', False) for Q2 Holdings. In the third quarter, Q2 Holdings showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $148.56 and a 52-week-low of $73.51. Q2 Holdings closed at $87.69 at the end of the last trading period.
Stephens & Co. initiated coverage on Ncino Inc NCNO with an Overweight rating. The price target for Ncino is set to ('$80.00', False). For the second quarter, Ncino had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. The current stock performance of Ncino shows a 52-week-high of $90.22 and a 52-week-low of $48.00. Moreover, at the end of the last trading period, the closing price was at $62.73.
With a Equal-Weight rating, Stephens & Co. initiated coverage on Jack Henry & Associates Inc JKHY. The price target seems to have been set at ('$165.00', False) for Jack Henry & Associates. Jack Henry & Associates earned $1.38 in the first quarter, compared to $1.19 in the year-ago quarter. The stock has a 52-week-high of $179.98 and a 52-week-low of $141.65. At the end of the last trading period, Jack Henry & Associates closed at $151.80.